Download PDF
Digestive Disease Interventions 2017; 01(01): 008-013
DOI: 10.1055/s-0037-1599255
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Imaging of Cholangiocarcinoma

Ronald S. Arellano
1   Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
,
Dushyant V. Sahani
2   Division of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

14 November 2016

30 January 2017

Publication Date:
22 March 2017 (online)

Also available at
   Permissions and Reprints

Abstract

Cross-section imaging plays an increasingly important role in the evaluation and diagnosis of cholangiocarcinoma (CC). CCs can have varied radiological appearances, depending on their location, morphology, as well as their histological characteristics. An awareness of the varied imaging manifestations of CC and its accurate diagnosis are necessary to direct appropriate management. Recent advances in imaging techniques, histological assessment, molecular imaging, surgical techniques, and radiation therapy have all revitalized interest in the diagnosis and management of CCs.

Keywords

cholangiocarcinoma - magnetic resonance imaging - cholangiography - computed tomography
 

  • References

  • 1 Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29 (2) 221-232
    CrossrefPubMedGoogle Scholar
  • 2 Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24 (2) 115-125
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Lee JH, Yang HM, Bak UB, Rim HJ. Promoting role of Clonorchis sinensis infection on induction of cholangiocarcinoma during two-step carcinogenesis. Korean J Parasitol 1994; 32 (1) 13-18
    CrossrefPubMedGoogle Scholar
  • 4 de Martel C, Plummer M, Franceschi S. Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 2010; 34 (3) 173-180
    CrossrefPubMedGoogle Scholar
  • 5 Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 1993; 2 (6) 537-544
    PubMedGoogle Scholar
  • 6 Bloom CM, Langer B, Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999; 19 (5) 1199-1218
    CrossrefPubMedGoogle Scholar
  • 7 Byrling J, Andersson B, Andersson R, Marko-Varga G. Cholangiocarcinoma--current classification and challenges towards personalised medicine. Scand J Gastroenterol 2016; 51 (6) 641-643
    CrossrefPubMedGoogle Scholar
  • 8 Singh P, Patel T. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 2006; 22 (3) 294-299
    CrossrefPubMedGoogle Scholar
  • 9 Hayashi A, Misumi K, Shibahara J , et al. Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma. Am J Surg Pathol 2016; 40 (8) 1021-1030
    CrossrefPubMedGoogle Scholar
  • 10 Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M. The concept of perihilar cholangiocarcinoma is valid. Br J Surg 2009; 96 (8) 926-934
    CrossrefPubMedGoogle Scholar
  • 11 Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69 (8) 1633-1637
    PubMedGoogle Scholar
  • 12 Kijima H, Wu Y, Yosizawa T , et al. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21 (7) 453-458
    CrossrefPubMedGoogle Scholar
  • 13 Nakanuma Y, Sasaki M, Ikeda H , et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res 2008; 38 (4) 325-334
    CrossrefPubMedGoogle Scholar
  • 14 Jarnagin WR, Fong Y, DeMatteo RP , et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234 (4) 507-517 , discussion 517–519
    CrossrefPubMedGoogle Scholar
  • 15 Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140 (2) 170-178
    PubMedGoogle Scholar
  • 16 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5 (7) 139-146
    CrossrefPubMedGoogle Scholar
  • 17 Ciombor KK, Goff LW. Current therapy and future directions in biliary tract malignancies. Curr Treat Options Oncol 2013; 14 (3) 337-349
    CrossrefPubMedGoogle Scholar
  • 18 Friman S. Cholangiocarcinoma--current treatment options. Scand J Surg 2011; 100 (1) 30-34
    CrossrefPubMedGoogle Scholar
  • 19 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2 (2) 94-107
    CrossrefPubMedGoogle Scholar
  • 20 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med 2012; 79 (2) 232-245
    CrossrefPubMedGoogle Scholar
  • 21 Nguyen KT, Steel J, Vanounou T , et al. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?. Ann Surg Oncol 2009; 16 (12) 3308-3315
    CrossrefPubMedGoogle Scholar
  • 22 Polydorou AA, Cairns SR, Dowsett JF , et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991; 32 (6) 685-689
    CrossrefPubMedGoogle Scholar
  • 23 Brugge WR. Endoscopic techniques to diagnose and manage biliary tumors. J Clin Oncol 2005; 23 (20) 4561-4565
    CrossrefPubMedGoogle Scholar
  • 24 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15 (34) 4240-4262
    CrossrefPubMedGoogle Scholar
  • 25 Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2012; 11 (1) 12-17
    CrossrefPubMedGoogle Scholar
  • 26 Butros SR, Shenoy-Bhangle A, Mueller PR, Arellano RS. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome. Clin Imaging 2014; 38 (4) 490-494
    CrossrefPubMedGoogle Scholar
  • 27 Sapisochin G, Facciuto M, Rubbia-Brandt L , et al; iCCA International Consortium Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 2016; 64 (4) 1178-1188
    CrossrefPubMedGoogle Scholar
  • 28 Hibi T, Itano O, Shinoda M, Kitagawa Y. Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun. Surg Today 2016; DOI: 10.1007/s00595-016-1337-1.
    PubMedGoogle Scholar
  • 29 Schmeding M, Neumann UP. Liver transplant for cholangiocarcinoma: a comeback?. Exp Clin Transplant 2015; 13 (4) 301-308
    CrossrefPubMedGoogle Scholar
  • 30 Brandi G, Venturi M, Pantaleo MA, Ercolani G GICO Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: a review of the literature and a long-standing experience of a referral center. Dig Liver Dis 2016; 48 (3) 231-241
    CrossrefPubMedGoogle Scholar
  • 31 Sungkasubun P, Siripongsakun S, Akkarachinorate K , et al. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area. BMC Cancer 2016; 16: 346
    CrossrefPubMedGoogle Scholar
  • 32 Koea J, Holden A, Chau K, McCall J. Differential diagnosis of stenosing lesions at the hepatic hilus. World J Surg 2004; 28 (5) 466-470
    CrossrefPubMedGoogle Scholar
  • 33 Neumaier CE, Bertolotto M, Perrone R, Martinoli C, Loria F, Silvestri E. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 1995; 23 (3) 173-178
    CrossrefPubMedGoogle Scholar
  • 34 Rosenthal SJ, Cox GG, Wetzel LH, Batnitzky S. Pitfalls and differential diagnosis in biliary sonography. Radiographics 1990; 10 (2) 285-311
    CrossrefPubMedGoogle Scholar
  • 35 Lupi L, Bighi S, Cervi PM, Marzola A. The CT and US aspects in hepatic cholangiocarcinoma due to thorium dioxide (thorotrast). A case report and review of the literature [in Italian]. Radiol Med (Torino) 1990; 79 (4) 399-401
    PubMedGoogle Scholar
  • 36 Colli A, Cocciolo M, Mumoli N , et al. Peripheral intrahepatic cholangiocarcinoma: ultrasound findings and differential diagnosis from hepatocellular carcinoma. Eur J Ultrasound 1998; 7 (2) 93-99
    CrossrefPubMedGoogle Scholar
  • 37 Singh A, Chandrashekhara SH, Handa N, Baliyan V, Kumar P. “Periportal neoplasms”--a CT perspective: review article. Br J Radiol 2016; 89 (1060) 20150756
    CrossrefPubMedGoogle Scholar
  • 38 Yata M, Suzuki K, Furuhashi N, Kawakami K, Kawai Y, Naganawa S. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma. Clin Radiol 2016; 71 (3) 203-210
    CrossrefPubMedGoogle Scholar
  • 39 Zhang H, Zhu J, Ke F , et al. Radiological imaging for assessing the respectability of hilar cholangiocarcinoma: a systematic review and meta-analysis. BioMed Res Int 2015; 2015: 497942
    PubMedGoogle Scholar
  • 40 Seo H, Lee JM, Kim IH , et al. Evaluation of the gross type and longitudinal extent of extrahepatic cholangiocarcinomas on contrast-enhanced multidetector row computed tomography. J Comput Assist Tomogr 2009; 33 (3) 376-382
    CrossrefPubMedGoogle Scholar
  • 41 Cho ES, Park MS, Yu JS, Kim MJ, Kim KW. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr 2007; 31 (1) 72-78
    CrossrefPubMedGoogle Scholar
  • 42 Lamba R, Fananapazir G, Corwin MT, Khatri VP. Diagnostic imaging of hepatic lesions in adults. Surg Oncol Clin N Am 2014; 23 (4) 789-820
    CrossrefPubMedGoogle Scholar
  • 43 Han JK, Choi BI, Kim AY , et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002; 22 (1) 173-187
    CrossrefPubMedGoogle Scholar
  • 44 Apisarnthanarak P, Pansri C, Maungsomboon K, Thamtorawat S. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma. J Med Assoc Thai 2014; 97 (4) 415-422
    PubMedGoogle Scholar
  • 45 Wu XP, Ni JM, Zhang ZY , et al. Preoperative evaluation of malignant perihilar biliary obstruction: negative-contrast CT cholangiopancreatography and CT angiography versus MRCP and MR angiography. AJR Am J Roentgenol 2015; 205 (4) 780-788
    CrossrefPubMedGoogle Scholar
  • 46 Sahani D, Saini S, Pena C , et al. Using multidetector CT for preoperative vascular evaluation of liver neoplasms: technique and results. AJR Am J Roentgenol 2002; 179 (1) 53-59
    CrossrefPubMedGoogle Scholar
  • 47 Youngson GG, Driver CP, Mahomed AA, Duddalwar VA. Computed tomographic cholangiography in the diagnosis of bile duct injury in children. J Pediatr Surg 2003; 38 (11) E18-E20
    PubMedGoogle Scholar
  • 48 Cabada Giadás T, Sarría Octavio de Toledo L, Martínez-Berganza Asensio MT , et al. Helical CT cholangiography in the evaluation of the biliary tract: application to the diagnosis of choledocholithiasis. Abdom Imaging 2002; 27 (1) 61-70
    CrossrefPubMedGoogle Scholar
  • 49 Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology 2004; 230 (3) 645-651
    CrossrefPubMedGoogle Scholar
  • 50 Zandrino F, Benzi L, Ferretti ML, Ferrando R, Reggiani G, Musante F. Multislice CT cholangiography without biliary contrast agent: technique and initial clinical results in the assessment of patients with biliary obstruction. Eur Radiol 2002; 12 (5) 1155-1161
    CrossrefPubMedGoogle Scholar
  • 51 Persson A, Dahlström N, Smedby O, Brismar TB. Three-dimensional drip infusion CT cholangiography in patients with suspected obstructive biliary disease: a retrospective analysis of feasibility and adverse reaction to contrast material. BMC Med Imaging 2006; 6: 1
    CrossrefPubMedGoogle Scholar
  • 52 Persson A, Dahlström N, Smedby O, Brismar TB. Volume rendering of three-dimensional drip infusion CT cholangiography in patients with suspected obstructive biliary disease: a retrospective study. Br J Radiol 2005; 78 (936) 1078-1085
    CrossrefPubMedGoogle Scholar
  • 53 Hänninen EL, Pech M, Jonas S , et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 2005; 46 (5) 462-470
    CrossrefPubMedGoogle Scholar
  • 54 Qian H, Li S, Ji M, Lin G. MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules. Eur J Gastroenterol Hepatol 2016; 28 (7) 749-756
    CrossrefPubMedGoogle Scholar
  • 55 Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2016; 44 (5) 1330-1338
    CrossrefPubMedGoogle Scholar
  • 56 Ciresa M, De Gaetano AM, Pompili M , et al. Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features. Eur Rev Med Pharmacol Sci 2015; 19 (15) 2786-2797
    PubMedGoogle Scholar
  • 57 Mamone G, Marrone G, Caruso S , et al. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase. Abdom Imaging 2015; 40 (7) 2313-2322
    CrossrefPubMedGoogle Scholar
  • 58 Adam SZ, Parthasarathy S, Miller FH. Intrahepatic cholangiocarcinomas mimicking other lesions. Abdom Imaging 2015; 40 (7) 2345-2354
    CrossrefPubMedGoogle Scholar
  • 59 Chung YE, Kim MJ, Park YN , et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 2009; 29 (3) 683-700
    CrossrefPubMedGoogle Scholar
  • 60 Vilgrain V. Staging cholangiocarcinoma by imaging studies. HPB (Oxford) 2008; 10 (2) 106-109
    CrossrefPubMedGoogle Scholar
  • 61 Yoon JH. Biliary papillomatosis: correlation of radiologic findings with percutaneous transhepatic cholangioscopy. J Gastrointestin Liver Dis 2013; 22 (4) 427-433
    PubMedGoogle Scholar
  • 62 Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24 (2) 155-164
    Article in Thieme ConnectPubMedGoogle Scholar
  • 63 Yin LL, Song B, Xu J, Li YC. Hilar cholangiocarcinoma: preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence. Chin Med J (Engl) 2007; 120 (8) 636-642
    PubMedGoogle Scholar
  • 64 Park DH, Kim MH, Lee SK , et al. Can MRCP replace the diagnostic role of ERCP for patients with choledochal cysts?. Gastrointest Endosc 2005; 62 (3) 360-366
    CrossrefPubMedGoogle Scholar
  • 65 Tse F, Barkun JS, Romagnuolo J, Friedman G, Bornstein JD, Barkun AN. Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford) 2006; 8 (6) 409-425
    CrossrefPubMedGoogle Scholar
  • 66 Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139 (7) 547-557
    CrossrefPubMedGoogle Scholar
  • 67 Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 2008; 33 (4) 444-451
    CrossrefPubMedGoogle Scholar
  • 68 Zhong L, Li L, Yao QY. Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques. World J Gastroenterol 2005; 11 (24) 3756-3761
    CrossrefPubMedGoogle Scholar
  • 69 Zhong L, Xiao SD, Stoker J, Nj Tytgat G. Magnetic resonance cholangiopancreatography. Chin J Dig Dis 2004; 5 (4) 139-148
    CrossrefPubMedGoogle Scholar
  • 70 Tsai TH, Hsu JS, Lai ML, Liu GC, Shih MC, Chen CY. Added value of diffusion-weighted imaging to MR cholangiopancreatography for the diagnosis of bile duct dilatations. Abdom Radiol (NY) 2016; 41 (3) 485-492
    CrossrefPubMedGoogle Scholar
  • 71 Wang J, Liu JJ, Liang YY , et al. Could diffusion-weighted imaging detect injured bile ducts of ischemic-type biliary lesions after orthotopic liver transplantation?. AJR Am J Roentgenol 2012; 199 (4) 901-906
    CrossrefPubMedGoogle Scholar
  • 72 Ustundag Y, Alper E, Fusaroli P. EUS-FNA versus ERCP-guided sampling for suspected malignant biliary obstruction: which to choose?. Gastrointest Endosc 2015; 81 (1) 241-242
    PubMedGoogle Scholar
  • 73 Téllez-Ávila FI, Bernal-Méndez AR, Guerrero-Vázquez CG, Martínez-Lozano JA, Ramírez-Luna MÁ. Diagnostic yield of EUS-guided tissue acquisition as a first-line approach in patients with suspected hilar cholangiocarcinoma. Am J Gastroenterol 2014; 109 (8) 1294-1296
    CrossrefPubMedGoogle Scholar
  • 74 Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors. Endoscopy 2006; 38 (Suppl. 01) S56-S60
    PubMedGoogle Scholar
  • 75 Fritscher-Ravens A, Broering DC, Knoefel WT , et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 2004; 99 (1) 45-51
    CrossrefPubMedGoogle Scholar
  • 76 Eloubeidi MA, Iseman DT, Chen VK, Vickers SM, Wilcox CM. Prevalence and significance of periduodenal venous collaterals in patients evaluated for pancreaticobiliary disorders by endosonography. Endoscopy 2003; 35 (12) 1015-1019
    Article in Thieme ConnectPubMedGoogle Scholar
  • 77 Elias Y, Mariano Jr AT, Lu Y. Detection of primary malignancy and metastases with FDG PET/CT in patients with cholangiocarcinomas: lesion-based comparison with contrast enhanced CT. World J Nucl Med 2016; 15 (3) 161-166
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-FDG PET/CT imaging in intrahepatic cholangiocarcinoma. Clin Nucl Med 2016; 41 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 79 Fritscher-Ravens A, Bohuslavizki KH, Broering DC , et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001; 22 (12) 1277-1285
    CrossrefPubMedGoogle Scholar
  • 80 Choi EK, Yoo IeR, Kim SH , et al. The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease. Clin Nucl Med 2013; 38 (3) e106-e111
    CrossrefPubMedGoogle Scholar